Results 1 to 10 of about 26,820 (222)
Activity Regulation by Fibrinogen and Fibrin of Streptokinase from Streptococcus Pyogenes. [PDF]
PLoS ONE, 2017 Streptokinase is a virulence factor of streptococci and acts as a plasminogen activator to generate the serine protease plasmin which promotes bacterial metastasis.
Sian Huish +2 more
doaj +2 more sources
Transient acute renal failure after coronary thrombolysis with streptokinase
Revista Cubana de Medicina Militar, 2021 Introduction: There are currently more than 150 medications related to the appearance of rhabdomyolysis and transient acute renal failure. Streptokinase can be one of them.
Rodolfo Vega Candelario +1 more
doaj +1 more source
Jurnal Teknologi Laboratorium, 2019 Streptokinase is a extracellular enzyme which is extracted from strains of beta Hemolytic streptococcus. The enzyme is a non-protease plasminogen activator that activates plasminogen to plasmin and degrades fibrin clot through its specific lysine binding
Pavan Kumar Vadla +2 more
doaj +3 more sources
Thrombolytic Therapy with Streptokinase in Acute Ischemic Stroke [PDF]
New England Journal of Medicine, 1996 The Multicenter Acute Stroke Trial — Europe Study Group
openalex +2 more sources
Microorganisms, 2022 Streptokinase is an enzyme that can break down the blood clots in some cases of myocardial infarction (heart attack), pulmonary embolism, and arterial thromboembolism.
Armi M. Chaudhari +5 more
doaj +1 more source
PLASMINOGEN ACTIVATION BY LOW MOLECULAR WEIGHT STREPTOKINASE AND FIBRIN EFFECT [PDF]
Biotechnologia Acta, 2014 The purpose is to study the plasminogen-activating activity of 36 kDa-streptokinase fragment, influences of desAB-fibrin on this process and low molecular weight streptokinase on plasmin catalytic properties as well. The 36 kDa-fragment lacking the 63
E. I. Yusova
doaj +1 more source
Acta Medica Iranica, 2022 Early administration of thrombolytic agents is standard for patients presenting with acute myocardial infarction (MI). Also, prolonged QT intervals indicate a higher risk for sudden death in patients with MI.
Reza Ghasemi +3 more
doaj +1 more source
Acta Medica Iranica, 2022 Early administration of thrombolytic agents is the standard treatment and crucial for the outcome for patients presenting with acute myocardial infarction (MI). This study was conducted to evaluate the door to needle time of streptokinase administration
Reza Ghasemi +3 more
doaj +1 more source
Egyptian Journal of Chest Disease and Tuberculosis, 2023 Context Parapneumonic effusion and empyema are commonly encountered by the pulmonologist. The decision regarding management is still challenging.
Mervat A Abou Ismail +3 more
doaj +1 more source
Contribution of Streptokinase-Domains from Groups G and A (SK2a) Streptococci in Amidolytic /Proteolytic Activities and Fibrin-Dependent Plasminogen Activation: A Domain-Exchange Study [PDF]
Iranian Biomedical Journal, 2020 Background: SK, a heterogeneous PA protein from groups A, C, and G streptococci (GAS, GCS, GGS, respectively) contains three structural domains (SKα, SKβ, and SK).
Maryam Rafipour +4 more
doaj +1 more source